How successful are you in grasping key opportunities to give/take a license and expand into attractive markets? How to optimize a business development strategy in times, when payers and patients are looking to save money wherever possible?
Leading generics players understand, how to establish and maintain partnerships, that will strengthen their position in key markets. Reveal, how to make licensing and partnering a key strategy to achieve a profitable growth. Utilize the market opportunities for biosimilars, understand, what are top selling products and expected expiry dates. Leading generics companies will share their first hand experience, how they tackle pricing, regulatory and IP challenges to ensure success of their business development strategy.
This event will bring together business development executives and senior experts from the generics industry presenting real life case studies as well as a lot of networking sessions and breaks specially designed for business discussions. Join us, meet new business partners & explore future partnering opportunities!
PLUS SPECIAL FEATURE!
Be a part of Business Networking Sessions!
Take the opportunity to meet your business partners, collect new business contacts and talk face to face in a series of business meetings
Expert Advisors
Strategic Planning and Head Licensing-In, Teva, Slovenia
SVP EU Business, Glenmark Generics, UK
General Manager, Zentiva, Turkey
Head In-Licensing, Zentiva, France
Head Portfolio Management, Ratiopharm, Austria
General Manager, Zydus Group, Spain
Senior Vice President EU Business, Glenmark Generics, UK
Head In-Licensing, Ranbaxy, India
Former CEO, TEVA, Spain
Vice President Business Development, Perrigo, Israel
Vice President Commercial Development, Winthrop, UK
Business Development Director, Abdi Ibrahim, Turkey
Marketing Director, Veropharm, Russia
Business Development Manager, Egis, Poland
into evolving trends in licensing & partnering - new business models for partnering in Europe & globally
Understand the pricing & regulatory scenario for generics in key markets
Exploit the market opportunities for biosimilars in emerging markets with Ranbaxy
Utilizing the licensing and partnership potential in dynamic CEE markets
Explore the business strategies of Russian manufacturers in generic portfolio development – learn about the government programs and healthcare reforms in Russia
Optimizing business development strategy in a new reality
Managing Intellectual Property challenges
CEOs, Managing Directors, Chief Licensing Officers, Vice Presidents, Senior Executives, Heads, Directors and Managers of: Business Development and Licensing, Licensing, Technology Licensing, Patent Licensing, Product Licensing & Development, Licensing & External Research, Regulatory Affairs, Strategic Planning, Corporate Development, Commercial Development, API, Sourcing API, Intellectual Property, Patent Attorneys, Supply & Logistics Operations, Contract Management
Request brochure:
